Home
Conditions
Epstein-Barr Virus Infections

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

692 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

NCT00134017

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

NCT00416312

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00002461

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

NCT01484015

Conditions: Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00119392

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

NCT00392834

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations: Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States

UCSF Medical Center at Parnassus San Francisco, California, United States

View all 13 locations

View Trial Details

Completed

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

NCT01129193

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +118 more
Locations: The Ohio State University James Cancer Hospital Columbus, Ohio, United States

View Trial Details

Epstein-Barr Virus Infections

Epstein-Barr Virus Infections trial results

Related conditions